Browse by author
Lookup NU author(s): Professor Roger Whittaker
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2024 International Federation of Clinical NeurophysiologyThis chapter discusses comprehensive neurophysiological biomarkers utilised in motor neuron disease (MND) and, in particular, its commonest form, amyotrophic lateral sclerosis (ALS). These encompass the conventional techniques including nerve conduction studies (NCS), needle and high-density surface electromyography (EMG) and H-reflex studies as well as novel techniques. In the last two decades, new methods of assessing the loss of motor units in a muscle have been developed, that are more convenient than earlier methods of motor unit number estimation (MUNE), and may use either electrical stimulation (e.g. MScanFit MUNE) or voluntary activation (MUNIX). Electrical impedance myography (EIM) is another novel approach for the evaluation that relies upon the application and measurement of high-frequency, low-intensity electrical current. Nerve excitability techniques (NET) also provide insights into the function of an axon and reflect the changes in resting membrane potential, ion channel dysfunction and the structural integrity of the axon and myelin sheath. Furthermore, imaging ultrasound techniques as well as magnetic resonance imaging are capable of detecting the constituents of morphological changes in the nerve and muscle. The chapter provides a critical description of the ability of each technique to provide neurophysiological insight into the complex pathophysiology of MND/ALS. However, it is important to recognise the strengths and limitations of each approach in order to clarify utility. These neurophysiological biomarkers have demonstrated reliability, specificity and provide additional information to validate and assess lower motor neuron dysfunction. Their use has expanded the knowledge about MND/ALS and enhanced our understanding of the relationship between motor units, axons, reflexes and other neural circuits in relation to clinical features of patients with MND/ALS at different stages of the disease. Taken together, the ultimate goal is to aid early diagnosis, distinguish potential disease mimics, monitor and stage disease progression, quantify response to treatment and develop potential therapeutic interventions.
Author(s): Shin-Yi Lin C, Howells J, Rutkove S, Nandedkar S, Neuwirth C, Noto Y-I, Shahrizaila N, Whittaker RG, Bostock H, Burke D, Tankisi H
Publication type: Review
Publication status: Published
Journal: Clinical Neurophysiology
Year: 2024
Volume: 162
Pages: 91-120
Print publication date: 01/06/2024
Online publication date: 20/03/2024
Acceptance date: 12/03/2024
ISSN (print): 1388-2457
ISSN (electronic): 1872-8952
Publisher: Elsevier Ireland Ltd
URL: https://doi.org/10.1016/j.clinph.2024.03.015
DOI: 10.1016/j.clinph.2024.03.015
